Detection of MPTP-Induced Substantia Nigra Hyperechogenicity in Rhesus Monkeys by Transcranial Ultrasound

Ultrasound in Medicine and Biology

Volumn 36, Issue 4, 2010, Pages 604-609

  Subramanian, Thyagarajan ^a   Lieu, Christopher A ^a   Guttalu, Kumaraswamy ^a   Berg, Daniela ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Basal ganglia; Macaca mulatta; Movement disorders; Nigrostriatal degeneration; Non human primate

Indexed keywords

NEURODEGENERATIVE DISEASES; ULTRASONIC IMAGING;

BASAL GANGLIA; MACACA MULATTA; MOVEMENT DISORDERS; NIGROSTRIATAL DEGENERATION; NON-HUMAN PRIMATE;

ANIMALS;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; IDIOPATHIC DISEASE; IMAGE ANALYSIS; LATERAL BRAIN VENTRICLE; MACACA; MESENCEPHALON; MOTOR DYSFUNCTION; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RHESUS MONKEY; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; TEMPORAL BONE;

EID: 77950338410     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2009.12.001     Document Type: Article

References (33)

1. Bankiewicz K.S., Oldfield E.H., Chiueh C.C., Doppman J.L., Jacobowitz D.M., Kopin I.J. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 1986, 39:7-16.
2. Behnke S., Berg D., Naumann M., Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005, 76:423-425.
3. Berg D. In vivo detection of iron and neuromelanin by transcranial sonography-A new approach for early detection of substantia nigra damage. J Neural Transm 2006, 113:775-780.
4. Berg D. Transcranial sonography in the early and differential diagnosis of Parkinson's disease. J Neural Transm Suppl 2006, 249-254.
5. Berg D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: Implications for idiopathic and monogenetic forms. Neurochem Res 2007, 32:1646-1654.
6. Berg D. Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener Dis 2008, 5:133-136.
7. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., Becker G. Brain iron pathways and their relevance to Parkinson's disease.[erratum appears in J Neurochem 2002;80:719]. J Neurochem 2001, 79:225-236.
8. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008, 7:1044-1055.
9. Berg D., Grote C., Rausch W.D., Maurer M., Wesemann W., Riederer P., Becker G. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999, 25:901-904.
10. Berg D., Hochstrasser H., Schweitzer K.J., Riess O. Disturbance of iron metabolism in Parkinson's disease - Ultrasonography as a biomarker. Neurotox Res 2006, 9:1-13.
11. Berg D., Jabs B., Merschdorf U., Beckmann H., Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 2001, 50:463-467.
12. Berg D., Merz B., Reiners K., Naumann M., Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005, 20:383-385.
13. Berg D., Roggendorf W., Schroder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., Becker G. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002, 59:999-1005.
14. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001, 248:684-689.
15. Eberling J.L., Jagust W.J., Taylor S., Bringas J., Pivirotto P., VanBrocklin H.F., Bankiewicz K.S. A novel MPTP primate model of Parkinson's disease: Neurochemical and clinical changes. Brain Res 1998, 805:259-262.
16. Fowler K.A., Huerkamp M.J., Pullium J.K., Subramanian T. Anesthetic protocol: Propofol use in Rhesus macaques (Macaca mulatta) during magnetic resonance imaging with stereotactic head frame application. Brain Res Brain Res Protoc 2001, 7:87-93.
17. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di Santo A., Schweitzer K.J., Gasser T., Machulla H.J., Reimold M., Marek K., Berg D. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study. Lancet Neurol 2008, 7:417-424.
18. He Y., Thong P.S., Lee T., Leong S.K., Mao B.Y., Dong F., Watt F. Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys. Free Radic Biol Med 2003, 35:540-547.
19. Oiwa Y., Eberling J.L., Nagy D., Pivirotto P., Emborg M.E., Bankiewicz K.S. Overlesioned hemiparkinsonian non human primate model: Correlation between clinical, neurochemical and histochemical changes. Front Biosci 2003, 8:a155-a166.
20. Prestel J., Schweitzer K.J., Hofer A., Gasser T., Berg D. Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord 2006, 21:1763-1765.
21. Ruprecht-Dorfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003, 18:416-422.
22. Ruprecht-Dorfler P., Klotz P., Becker G., Berg D. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 2007, 13:362-364.
23. Schweitzer K.J., Brussel T., Leitner P., Kruger R., Bauer P., Woitalla D., Tomiuk J., Gasser T., Berg D. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. J Neurol 2007, 254:613-616.
24. Schweitzer K.J., Hilker R., Walter U., Burghaus L., Berg D. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov Disord 2006, 21:94-98.
25. Stockner H., Iranzo A., Seppi K., Serradell M., Gschliesser V., Sojer M., Valldeoriola F., Molinuevo J.L., Frauscher B., Schmidauer C., Santamaria J., Hogl B., Tolosa E., Poewe W. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2009, 10.1002/mds.22483.
26. Subramanian T., Deogaonkar M., Brummer M., Bakay R. MRI guidance improves accuracy of stereotaxic targeting for cell transplantation in parkinsonian monkeys. Exp Neurol 2005, 193:172-180.
27. Subramanian T., Emerich D.F., Bakay R.A., Hoffman J.M., Goodman M.M., Shoup T.M., Miller G.W., Levey A.I., Hubert G.W., Batchelor S., Winn S.R., Saydoff J.A., Watts R.L. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplant 1997, 6:469-477.
28. Walter U., Dressler D., Lindemann C., Slachevsky A., Miranda M. Transcranial sonography findings in welding-related parkinsonism in comparison to Parkinson's disease. Mov Disord 2008, 23:141-145.
29. Walter U., Dressler D., Probst T., Wolters A., Abu-Mugheisib M., Wittstock M., Benecke R. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007, 64:1635-1640.
30. Walter U., Dressler D., Wolters A., Wittstock M., Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 2007, 22:48-54.
31. Walter U., Niehaus L., Probst T., Benecke R., Meyer B.U., Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003, 60:74-77.
32. Walter U., Wagner S., Horowski S., Benecke R., Zettl U.K. Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 2009, 73:1010-1017.
33. Zecca L., Berg D., Arzberger T., Ruprecht P., Rausch W.D., Musicco M., Tampellini D., Riederer P., Gerlach M., Becker G. In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage. Mov Disord 2005, 20:1278-1285.